JPH06506587A - 繊維状赤血球凝集素（ｆｈａ）を発現するプラスミド類とその宿主 - Google Patents

繊維状赤血球凝集素（ｆｈａ）を発現するプラスミド類とその宿主

Info

Publication number
JPH06506587A
JPH06506587A JP4507977A JP50797792A JPH06506587A JP H06506587 A JPH06506587 A JP H06506587A JP 4507977 A JP4507977 A JP 4507977A JP 50797792 A JP50797792 A JP 50797792A JP H06506587 A JPH06506587 A JP H06506587A
Authority
JP
Japan
Prior art keywords
plasmid
fha
region
dna
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4507977A
Other languages
English (en)
Japanese (ja)
Inventor
ティミス，ケネト
グツマン，カルロス
ウォーカー，マーク
Original Assignee
ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ）
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ） filed Critical ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング（ゲー・ベー・エフ）
Publication of JPH06506587A publication Critical patent/JPH06506587A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP4507977A 1991-04-09 1992-04-09 繊維状赤血球凝集素（ｆｈａ）を発現するプラスミド類とその宿主 Pending JPH06506587A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4111531,7 1991-04-09
DE4111531A DE4111531A1 (de) 1991-04-09 1991-04-09 Plasmide zur fha-expression und wirte
PCT/EP1992/000814 WO1992018624A1 (de) 1991-04-09 1992-04-09 Plasmide zur fha-expression und wirte

Publications (1)

Publication Number Publication Date
JPH06506587A true JPH06506587A (ja) 1994-07-28

Family

ID=6429180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4507977A Pending JPH06506587A (ja) 1991-04-09 1992-04-09 繊維状赤血球凝集素（ｆｈａ）を発現するプラスミド類とその宿主

Country Status (4)

Country Link
EP (1) EP0579685A1 (de)
JP (1) JPH06506587A (de)
DE (1) DE4111531A1 (de)
WO (1) WO1992018624A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341123C (en) * 1988-10-27 2000-10-17 David A. Relman Filamentous hemagglutinin of b. pertussis
EP0392605A1 (de) * 1989-04-13 1990-10-17 Merck & Co. Inc. Methode zur Steigerung der Expression des sauren Fibroblast-Wachstumsfaktors

Also Published As

Publication number Publication date
WO1992018624A1 (de) 1992-10-29
DE4111531A1 (de) 1992-10-29
EP0579685A1 (de) 1994-01-26

Similar Documents

Publication Publication Date Title
Suk et al. Borrelia burgdorferi genes selectively expressed in the infected host.
Agterberg et al. Outer-membrane PhoE protein of Escherichia coli K-12 as an exposure vector: possibilities and limitations
US5547664A (en) Expression of recombinant proteins in attenuated bacteria
CA2013573C (en) Vaccines containing avirulent phop-type microorganisms
Curtiss III et al. Avirulent Salmonella typhimurium Δcya Δcrp oral vaccine strains expressing a streptococcal colonization and virulence antigen
Agterberg et al. Outer membrane PhoE protein of Escherichia coli as a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus
Hamid et al. Characterization of an outer membrane protein of Salmonella enterica serovar Typhimurium that confers protection against typhoid
Barry et al. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908
EP0629696A1 (de) Analoge der Untereinheit des von rekombinanter DNS abgeleiteten Bordetella Toxins
JPH06277066A (ja) 髄膜炎菌“Ｎｅｉｓｓｅｒｉａ ｍａｎｉｎｇｉｔｉｄｉｓ”のトランスフェリン受容体のサブユニットをコードするＤＮＡ断片と、その製造方法
JPH08503602A (ja) 弱毒化細菌における組換え融合タンパク質の発現
AU2002321644B2 (en) Bacterial vaccine
White et al. High efficiency gene replacement in Salmonella enteritidis: chimeric fimbrins containing a T-cell epitope from Leishmania major
JPH11103872A (ja) クロストリジゥムパーフリンジェンスワクチン
TWI241407B (en) Live attenuated bacteria of the species actinobacillus pleuropneumoniae
Sirard et al. A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins
Smerdou et al. A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity
Smerdou et al. Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium Δcya Δcrp: persistence, stability and immune response in swine
JPH06506587A (ja) 繊維状赤血球凝集素（ｆｈａ）を発現するプラスミド類とその宿主
Galan et al. Expression and localization of the Streptococcus equi M protein in Escherichia coli and Salmonella typhimurium
AU629793B2 (en) Cholera vaccines
WO1996026282A1 (en) Expression of gene products from genetically manipulated strains of bordetella
Elkins et al. Cloning and constitutive expression of structural genes encoding gonococcal porin protein in Escherichia coli and attenuated Salmonella typhimurium vaccine strains
Guzman et al. Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA
CN108611372A (zh) 一种免疫原性增强型猪传染性胃肠炎s基因复制缺陷型重组腺病毒的制备方法